These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [PRESENT STATUS OF ANTICOAGULANT THERAPY]. IKEDA M; HOSODA M Rinsho Naika Shonika Intern Med; 1964 Jan; 19():17-34. PubMed ID: 14115807 [No Abstract] [Full Text] [Related]
4. [COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS]. IAROSHEVSKII AIa; ZHAVORONKOVA EK Ter Arkh; 1964 Jan; 36():36-42. PubMed ID: 14149441 [No Abstract] [Full Text] [Related]
5. The current status of therapy with anticoagulants. Borden CW Med Clin North Am; 1972 Jan; 56(1):235-53. PubMed ID: 4550292 [No Abstract] [Full Text] [Related]
6. [HEPARIN IN CARDIOVASCULAR THERAPEUTICS]. D OCZY P; SZIGETI I Med Interna (Bucur); 1964 Jan; 16():1-12. PubMed ID: 14132687 [No Abstract] [Full Text] [Related]
7. OFFICE MANAGEMENT OF THE ANTICOAGULATED PATIENT. UDALL JA Geriatrics; 1964 Jul; 19():505-10. PubMed ID: 14183246 [No Abstract] [Full Text] [Related]
8. [BEHAVIOR OF FIBRINOLYSIS IN PATIENTS TREATED WITH COUMARIN ANTICOAGULANTS]. CROLLE G; BRUSASCO A Minerva Med; 1963 Nov; 54():3479-82. PubMed ID: 14121435 [No Abstract] [Full Text] [Related]
9. [Prothrombin activity of the blood and tolerance of the plasma to heparin in stenocardia and myocardial infarct]. MALIAROVSKII VN Ter Arkh; 1960 Mar; 32():73-5. PubMed ID: 14420304 [No Abstract] [Full Text] [Related]
12. [COMPARATIVE EVALUATION OF THROMBOELASTOGRAPHIC DATA AND SOME BIOCHEMICAL INDICES IN MYOCARDIAL INFARCT AND STENOCARDIA PATIENTS DURING ANTICOAGULANT THERAPY]. ROMASHOV VP Ter Arkh; 1964 Jun; 36():11-7. PubMed ID: 14226949 [No Abstract] [Full Text] [Related]
13. "THROMBOTEST" AND PROTHROMBIN TIME: A CONTROLLED CLINICAL TRIAL. ROZENBERG MC; KRONENBERG H; FIRKIN BG Australas Ann Med; 1965 Feb; 14():3-12. PubMed ID: 14271789 [No Abstract] [Full Text] [Related]
14. A critical evaluation of anticoagulant therapy. Wright IS Geriatrics; 1969 Mar; 24(3):96-100. PubMed ID: 4885555 [No Abstract] [Full Text] [Related]
15. INCREASED SENSITIVITY TO HEPARIN FOLLOWING ACUTE MYOCARDIAL INFARCTION. DUFAULT C Can Med Assoc J; 1965 Jan; 92(1):13-5. PubMed ID: 14216140 [TBL] [Abstract][Full Text] [Related]
16. CONTROLLED STUDY OF THE EFFECTIVE LEVEL OF LONG-TERM ANTICOAGULATION. MOSCHOS CB; WONG PC; SISE HS JAMA; 1964 Nov; 190():799-805. PubMed ID: 14202822 [No Abstract] [Full Text] [Related]
17. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases]. Verstraete M Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864 [No Abstract] [Full Text] [Related]
18. ANTICOAGULANT DRUG THERAPY IN ACUTE CORNONARY THROMBOSIS AND ALLIED CONDITIONS. MASTER AM; RUSSEK HI; WRIGHT I Dis Chest; 1964 Jun; 45():572-85. PubMed ID: 14168525 [No Abstract] [Full Text] [Related]
19. [EXPERIENCE IN THE CLINICAL USE OF FIBRINOLYSIN]. PANCHENKO VM; ANDREENKO GV Ter Arkh; 1964 Jan; 36():43-51. PubMed ID: 14149444 [No Abstract] [Full Text] [Related]
20. EFFECT OF SUDDEN WITHDRAWAL OF LONG-TERM ANTICOAGULANT THERAPY ON THE HEPARIN RESISTANCE AND PLASMA FIBRINOGEN LEVEL. COTTON RC; WADE EG Clin Sci; 1964 Apr; 26():337-43. PubMed ID: 14162427 [No Abstract] [Full Text] [Related] [Next] [New Search]